No Detail Found!

Exploring the Role of Anti-Müllerian Hormone (AMH) as a Biomarker for Female Infertility

Author(s)
Abeer Ali Hameed Department of Chemistry, College of Education of Pure Science, University of Diyala, 320001, Iraq
Abeer Najim Abdullah Department of Chemistry, College of Education of Pure Science, University of Diyala, 320001, Iraq
Ali Abbas Ali Department of Chemistry, College of Education of Pure Science, University of Diyala, 320001, Iraq
Abstract
Background: Anti-Müllerian Hormone (AMH), Follicle-Stimulating Hormone (FSH), and Prolactin are key hormonal markers in female reproductive function. AMH and FSH assess ovarian reserve, while Prolactin reflects pituitary activity. Methods: A cross-sectional study was conducted on 29 infertile women. Serum levels of AMH, FSH, and Prolactin were measured. Pearson correlation and ROC analysis were performed to examine relationships and diagnostic performance. Results: No statistically significant correlations were found between AMH and FSH (r = 0.217, p = 0.258), AMH and Prolactin (r = -0.119, p = 0.539), or FSH and Prolactin (r = -0.185, p = 0.336). ROC analysis showed that Prolactin had high diagnostic accuracy (AUC = 0.983), whereas AMH and FSH demonstrated limited utility. Conclusion: Within this small cohort, expected hormonal correlations were not observed. Prolactin shows potential as a diagnostic biomarker, while AMH and FSH should be interpreted cautiously. Larger, well-designed studies are recommended to validate these findings.
Publication Details
Page(s) 117-122
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 12, Year: 2025

Request the full text from PASTIC

Keywords
Biomarker, Ovarian reserve, Reproductive Health, anti-Müllerian Hormone (AMH), Female infertility
References
Dason E.S. . .Diagnosis and management of polycystic ovarian syndrome. ” CMAJ, 10(2024) : E85-E94.
Broer S.L. . .AMH: Ovarian reserve testing and its potential clinical implications. ” Human Reproduction Update, 10(2014) : 688-701.
Piltonen .2024 .Validation of an anti-Müllerian hormone cutoff for polycystic ovarian morphology in the diagnosis of polycystic ovary syndrome in the HARMONIA study. e48854. doi:10, 13 : .
Sivanandy M.S.,Ha S.K. . .The role of serum antiMüllerian hormone measurement in the diagnosis of polycystic ovary syndrome. ” Diagnostics, 10(2023) : 907.
Miyake N. . .Association between anti-Müllerian hormone levels and polycystic ovary syndrome in a general cohort of young women in Japan. e12615. doi:10.1002/rmb2, 23(2024) : 12615.
Marca La,A. La .2006 .Serum anti-Müllerian hormone throughout the human menstrual cycle. ” Human Reproduction, 10(12) : 3103-3107.
Li H.W. .2013 .Variation of anti-Müllerian hormone measurement during the menstrual cycle-A prospective cohort study. ” Fertility and Sterility, 01(2016) : 627-634.
Karkanaki A. . .The clinical significance of antiMüllerian hormone testing in reproductive endocrinology. ” Hormones, 18(2019) : 403-411.
Visser J.A. . .Anti-Müllerian hormone: a new marker for ovarian function. ” Reproduction, 131(2012) : 1-9.
Al-Taee H.A.J.,Al-Sallami S.W. . .Iraqi experience in the assessment of anti-Müllerian hormone utilisation in clinical practice: an overview. Medical Journal of Babylon, 970(2023) : 23-669.
Rashid D.,Bardan D. .2022 .Anti-Müllerian hormone serum level as a predictor of responsiveness to clomiphene citrate therapy in Iraqi women with PCOS. ” Open Access Macedonian Journal of Medical Sciences, 8691 : 1-7.
Alhassan S. .2023 .Diagnostic performance of anti-Müllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among Sudanese women. International Journal of Women's Health, 10 : 837-843.
Anand S. . .Updated meta-analysis on the diagnostic accuracy of serum anti-Müllerian hormone in polycystic ovary syndrome involving 13,509 subjects. Journal of Obstetrics and Gynaecology Research, 10(2022) : 2162-2174.
Taylor .2020 .Examining the link between positive affectivity and anxiety reactivity to social stress in individuals with and without social anxiety disorder. ” Journal of Anxiety Disorders, 102264 : 102264.
Zhao Y. .2019 .Diagnostic value of anti-Müllerian hormone as a biomarker for polycystic ovary syndrome: a metaanalysis update. ” Endocrine Practice, 10(10) : 1056-1066.
Van der Ham K. .2024 .Anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis. ” Fertility and Sterility, 05(2024) : 727-739.
Dewailly D. . .The physiology and clinical utility of anti-Müllerian hormone in women. ” Human Reproduction Update, 10(2014) : 370-385.
Tsukui Y. . .Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: A systematic review and meta-analysis. ” Endocrine Journal, 0081(2022) : 897-906.
Aslan Kiper,A. Kiper .2025 .Age-stratified analysis of anti-Müllerian hormone levels and the prevalence of diminished ovarian reserve in women aged 18-45. , 1612194 : 1-10.
Deswal R. .2020 .The prevalence of polycystic ovary syndrome: a brief systematic review. ” Journal of Human Reproductive Sciences, 95 : 18-271.
Hamid M.H.A. . .A randomized controlled trial comparing WALANT to general anesthesia in plating of distal radius fractures. e12876. doi:10, 13(2021) : .
Dehghan E. .2022 .Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd infertility centre: a cross-sectional study. International Journal of Reproductive BioMedicine, 10(12) : 10059-1090.
0

Citations

0

Downloads

14

Views